Effect of serotonergic lesion on “anxious” behaviour measured in the elevated plus-maze test in the rat

Abstract5,7-Dihydroxytryptamine (250 µg) was administered intracerebroventricularly to rats to lesion central serotonergic neurones. Fourteen days later the rats were tested in the elevated plus-maze “anxiety” model in comparison to sham lesioned animals. Twenty-four hours later, the rats were killed and serotonin levels and [3H]paroxetine binding measured in cortical and hippocampal membranes. The lesion destroyed 81% of the serotonergic innervation in the cortex and 99% in the hippocampus as determined by endogenous serotonin levels. Lesioned rats had an increased ratio of open/total arm entries in the elevated plus-maze, reflecting a decreased level of “anxiety”. These results are compatible with the implication of serotonin in the control of anxiety and suggest that an anxiolytic effect may be induced by lowering the level of serotonergic activation.

[1]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[2]  H. Westenberg,et al.  L-5-hydroxytryptophan in the treatment of anxiety disorders. , 1985, Journal of affective disorders.

[3]  S. Woods,et al.  Serotonin function in anxiety , 1987, Psychopharmacology.

[4]  C. Fischette,et al.  Effects of 5, 7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography , 1987, Brain Research.

[5]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[6]  P. Chopin,et al.  Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission , 1987 .

[7]  S. File,et al.  5,7-dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. , 1979, Journal of affective disorders.

[8]  S. Iversen,et al.  The effects of benzodiazepines and serotonergic manipulations on punished responding , 1979, Neuropharmacology.

[9]  P. Soubrié,et al.  Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat , 2004, Psychopharmacology.

[10]  S. Iversen,et al.  5-Hydroxytryptamine and punishment , 1977, Nature.

[11]  P. Soubrié,et al.  Attenuation of induced-anxiety in rats by chlordiazepoxide: Role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons , 1982, Neuroscience.

[12]  Y. Claustre,et al.  Characterization of [3H]paroxetine binding to rat cortical membranes. , 1985, European journal of pharmacology.

[13]  L Stein,et al.  Benzodiazepines: Anxiety-Reducing Activity by Reduction of Serotonin Turnover in the Brain , 1972, Science.

[14]  M. Carli,et al.  Evidence that central 5‐hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone , 1989, British journal of pharmacology.